These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 391006)
21. Clinical effectiveness of commonly used oral bronchodilators in asthmatic children. Whitcomb NJ; Rubinstein E Ann Allergy; 1973 Dec; 31(12):603-6. PubMed ID: 4586256 [No Abstract] [Full Text] [Related]
22. [Abnormal bronchomotor effects of adrenergics. Experimental interpretations and therapeutic deductions]. Harichaux P; Baudouin J Lille Med; 1967 Feb; 12(2):172-7. PubMed ID: 5606383 [No Abstract] [Full Text] [Related]
23. A double-blind trial of 'nethaprin dospan' in chronic asthmatic children. Weinberg EG; Shore SC; Anderton M Curr Med Res Opin; 1974; 2(4):222-30. PubMed ID: 4601975 [No Abstract] [Full Text] [Related]
24. On the use of selected bronchodilators in the asthmatic and non-asthmatic patient. Chrow L AANA J; 1978 Aug; 46(4):389-96. PubMed ID: 716823 [No Abstract] [Full Text] [Related]
25. [Use of sympathomimetics in the treatment of asthma]. Hugues FC; Julien D Poumon Coeur; 1978; 34(2):119-26. PubMed ID: 673998 [TBL] [Abstract][Full Text] [Related]
26. Double-blind evaluation of an anti-asthmatic agent. Unger DL; Unger L; Temple DE Ann Allergy; 1967 Oct; 25(10):575-7. PubMed ID: 4861739 [No Abstract] [Full Text] [Related]
28. [Clinical and respiratory function technical studies of the new drug combination Asthmadyn-R in asthmatic clinical states]. Gürtler J Praxis; 1967 Oct; 56(41):1401-6. PubMed ID: 5633081 [No Abstract] [Full Text] [Related]
29. Doxofylline: a new generation xanthine bronchodilator devoid of major cardiovascular adverse effects. Dini FL; Cogo R Curr Med Res Opin; 2001; 16(4):258-68. PubMed ID: 11268710 [TBL] [Abstract][Full Text] [Related]
30. Drug therapy of bronchial asthma. O'Loughlin JM Med Clin North Am; 1979 Mar; 63(2):391-6. PubMed ID: 35721 [No Abstract] [Full Text] [Related]
31. [The therapy of the asthmatic patient with Par-Isalon]. Mathey HG Landarzt; 1966 Feb; 42(5):217-9. PubMed ID: 4382465 [No Abstract] [Full Text] [Related]
32. [Clinical experiences with delayed action Perspiran in obstructive respratory disorders]. Dlouhy R Med Welt; 1967 Aug; 33():1918-21. PubMed ID: 5590200 [No Abstract] [Full Text] [Related]
33. The combined action of broncholytic agents in asthmatic patients: orciprenaline, isoprenaline, and ephedrine. Muittari A; Mattila MJ; Tiitinen H Ann Med Intern Fenn; 1968; 57(1):31-5. PubMed ID: 4882181 [No Abstract] [Full Text] [Related]
34. [Clinical study of a new pharmacologic combination in the therapy of allergic respiratory diseases]. Dolcetti A; Motta PE; Gaino T Clin Ter; 1969 Jan; 48(2):145-50. PubMed ID: 4396736 [No Abstract] [Full Text] [Related]
35. [Attempted clinical classification of asthma. New therapeutic agent with a prolonged effect]. Dubois de Montreynaud JM; Kochman S; Cazabat A; Candas JC Therapeutique; 1971 Oct; 47(8):699-703. PubMed ID: 5129919 [No Abstract] [Full Text] [Related]
36. Pharmacological aspects of bronchodilators. Frewin DB Aust Fam Physician; 1979 Jan; 8(1):69-71. PubMed ID: 35145 [No Abstract] [Full Text] [Related]
37. Objective assessment of a bronchodilator drug combination in asthmatic outpatients. Mattila MJ; Alanko K Curr Ther Res Clin Exp; 1973 Jun; 15(6):273-84. PubMed ID: 4197251 [No Abstract] [Full Text] [Related]